As of 2024-12-11, the Relative Valuation of Faron Pharmaceuticals Oy (FARN.L) is (262.84) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 192.50 GBP, the upside of Faron Pharmaceuticals Oy based on Relative Valuation is -236.5%.
The range of the Relative Valuation is (319.23) - (278.61) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 25.8x | 16.7x |
| Forward P/E multiples | 4.2x - 11.7x | 5.3x |
| Fair Price | (319.23) - (278.61) | (262.84) |
| Upside | -265.8% - -244.7% | -236.5% |
| Date | P/E |
| 2024-11-21 | -4.86 |
| 2024-11-20 | -4.84 |
| 2024-11-19 | -4.93 |
| 2024-11-18 | -4.93 |
| 2024-11-15 | -4.93 |
| 2024-11-14 | -5.01 |
| 2024-11-13 | -5.09 |
| 2024-11-12 | -5.34 |
| 2024-11-11 | -5.42 |
| 2024-11-08 | -5.01 |
| 2024-11-07 | -5.01 |
| 2024-11-06 | -5.17 |
| 2024-11-05 | -5.12 |
| 2024-11-04 | -5.42 |
| 2024-11-01 | -5.42 |
| 2024-10-31 | -5.42 |
| 2024-10-30 | -5.67 |
| 2024-10-29 | -5.83 |
| 2024-10-28 | -5.75 |
| 2024-10-25 | -5.91 |
| 2024-10-24 | -5.75 |
| 2024-10-23 | -5.83 |
| 2024-10-22 | -6.11 |
| 2024-10-21 | -6.83 |
| 2024-10-18 | -7.03 |
| 2024-10-17 | -7.03 |
| 2024-10-16 | -7.06 |
| 2024-10-15 | -6.73 |
| 2024-10-14 | -6.86 |
| 2024-10-11 | -7.00 |
| 2024-10-10 | -7.06 |
| 2024-10-09 | -7.32 |
| 2024-10-08 | -7.32 |
| 2024-10-07 | -7.26 |
| 2024-10-04 | -7.29 |
| 2024-10-03 | -7.39 |
| 2024-10-02 | -7.39 |
| 2024-10-01 | -7.49 |
| 2024-09-30 | -7.49 |
| 2024-09-27 | -7.19 |
| 2024-09-26 | -7.06 |
| 2024-09-25 | -7.06 |
| 2024-09-24 | -6.93 |
| 2024-09-23 | -7.06 |
| 2024-09-20 | -7.06 |
| 2024-09-19 | -7.09 |
| 2024-09-18 | -7.36 |
| 2024-09-17 | -7.46 |
| 2024-09-16 | -7.46 |
| 2024-09-13 | -7.26 |